Top Bulls Reasons To Buy — Vote below!

Add a New Bulls Reason

Company: Aastrom Biosciences (ASTM)
Current price:
Headline: (100 character max)
Analysis:
Cancel
100%
agree
2 votes

  should be 1.00+ in 2 months

could be more

(100 character max) Cancel
100%
agree
1 votes

  Stem cell research, free at last!

Finally, after almost a decade of limiting taxpayer money for research president Barrack Obama has lifted the restrictions on federal funding of human embryonic stem cell research today.

Back in 2001 George W. Bush restricted funding stem cell research to only a few stem cells that had been created prior to Aug. 9, 2001. This decision was based on politics and religion rather than science. Since then the rest of the world has taken a huge step forward in understanding and bringing commercial products closer to the market than the U.S.

For those unaware embryonic stem cells are pluripotent, meaning they have the ability to form into any cell type that make up the human body. Scientists across the globe (except the U.S.) hope to utilize them to regenerate brain cells lost in Parkinson's, repairing spinal cord injuries as well as treating diabetes, cancer, heart disease, multiple sclerosis and many more defects. Stem cells also help in understanding the human development and growth of diseases. If scientists can map the growth of a disease they will have a greater chance at forming treatments.

Let's think of how many Americans are suffering from the aforementioned ailments and what this research can do for them. I'm sure everyone reading this knows someone important to them that is affected by one of these maladies. Research in the U.S.has not progressed since earlier this decade, cures are a very long time away and lets not even discuss the approval requirement by the FDA. At least this can be seen as a huge step forward to join the rest of the world at bringing about cures that could help millions of people including you and I some day.

(100 character max) Cancel
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki